Cancer diagnosis and treatment bring myriad other conditions like insomnia, fatigue and cognitive decline. These can lead to mood or anxiety disorders. Dr. David Silver discusses cancer diagnosis and depression in women.

The American Cancer Society estimates that one in six men will be diagnosed with prostate cancer in his lifetime.

Since prostate cancer is the most common cancer in American men after skin cancer and long-term survival is common, after diagnosis and treatment, survivors have continuing needs for follow-up care to manage treatment side effects. They may also need tests to see if the cancer has come back, and treat other health conditions.

Here to speak with us today about prostate cancer survivorship is Dr Shubham Gupta, he is a urologist with UK HealthCare.

Ravikumar Paluri, MD, Rojymon Jacob, MD, and Greg Kennedy, MD, join the segment in this panel discussion on the benefits of multi-disciplinary care for Colorectal Cancer patients, and when to refer to the specialists at UAB Medicine.

A new test for urothelial cancers could detect mutations in DNA that have been identified for those cancers earlier than traditional tests. The earlier detection of urothelial cancer could lead to earlier treatment, and potentially better outcomes for patients.

George Netto, MD, Pathology Department Chair at UAB, discusses the UroSEEK non-invasive test that he helped to develop, that uses urine samples to seek out mutations in 11 genes that indicate the presence of DNA associated with bladder cancer or upper tract urothelial cancer (UTUC).

New advancements in cancer therapies are helping patients live longer, however, this also means that ongoing cancer treatments may damage their hearts. Cardio-Oncologist, Carrie Lenneman MD, shares her expertise in this very specialized field of medicine.

Adoptive cell transfer (ACT) is an emerging approach to immunotherapy by which patients' own immune cells are collected and used to treat their cancer. There are several types of ACT, but the one that seems to be closest to producing an FDA-approved treatment is chimeric antigen receptor (CAR) T-cell therapy.

The UAB Medicine Robotic Surgery Program is one of the largest in the Southeast and has the largest surgical volume in the country, with nearly 25 surgeons using the da Vinci robot to perform almost 1,000 surgeries each year. UAB Robotic Surgery includes several fellowship-trained subspecialists who have received the maximum training in their field. UAB regularly sets new surgical standards and attracts hundreds of surgeons from around the world for observation and educational sessions involving the da Vinci robot.

Joining the show to discuss training in robotic surgery at UAB Medicine is Dr. Kenneth Hyun-Chung Kim. He is an associate professor who specializes in Obstetrics & Gynecology and Gynecologic Oncology at UAB Medicine.

For more information about our Surgical Training Programs, explore the webpages below.

The University of Alabama at Birmingham is joining a growing network charged with implementing the National Institutes of Health's All of Us Research Program, an ambitious effort to advance research into precision medicine.

In this segment, Eddy S Yang, MD, PhD, discuss precision oncology and what it may mean as a blue print for future research.

UAB surgeons are pioneering procedures for robotic surgery for head-and-neck, lung, and other cancers to help push the technology far beyond its original emphasis on prostate cancer. In the process, UAB has become one of the busiest, most diverse, and most comprehensive robotic surgery programs in the nation with more than 20 surgeons in nine specialties performing more than 900 surgeries annually.

Of the surgeries at UAB, fully 75 percent are oncologic.

In this exciting segment, Dr. John R. Porterfield joins the show to share how UAB is setting new surgical standards and pushing the robotic surgery platform into previously untouched frontiers in a variety of fields.

For more information about our Surgical Training Programs, explore the webpages below.

Transarterial-chemoembolization (TACE) has been a palliative treatment or bridging treatment for liver cancer, whether primary or metastatic. TACE is a combination of local delivery of chemotherapy and a procedure to block of the blood supply to the tumor and trap the chemotherapy in the tumor.

The UAB Medicine Breast Cancer Survivorship Program offers specialized follow-up care focused on the unique needs of breast cancer patients. The goal of the program is to help each survivor stay as healthy as possible and to prevent problems from happening or catch them early, when they are most easily treat.

In this segment Smita Bhatia, MD, discusses breast cancer survivorship, the future of cancer survivorship and how UAB is leading the way in care and research.

In the world of electronic health records, and an increase in the aging population, many physicians find themselves subjected to more intense scrutiny of quality and performance, while they face an ever increasing patient load. They can experience depression and burnout the way many professional do, however, as physicians they may be tempted to care for others before they care for themselves.

Here to discuss the consequences and possible solutions to worrisome physician burnout is J. Michael Straughn Jr.,MD. He is a Gynecologic Oncologist at UAB Medicine.

The thyroid gland influences many of the metabolic processes in your body through the hormone that it produces. As a result, thyroid disorders can be far reaching and can range from nodules to hypothyroidism to life threatening cancer.

In this panel discussion regarding thyroid cancer and thyroid disease are Dr. Benjamin Greene, Dr. Brian Hughley and Dr. Erin Buczek. They are head and neck surgeons at UAB Medicine

Every year approximately 100,000 people in the United States are diagnosed with head and neck cancer. The Head and Neck Oncology Division of the UAB Department of Otolaryngology (ear, nose, and throat) is among the largest of its kind in the United States. Our providers diagnose and treat tumors of the oral cavity, oropharynx (throat), larynx (voice box), sinuses, skull base, salivary glands, and skin.

UAB was among the first hospitals nationally to offer robot-assisted resection of head and neck tumors, and we continue to be at the forefront of this growing area of head and neck surgery.

Here today in a panel discussion regarding the intricate nature of head and neck cancer, facial reconstruction and how it affects the daily lives of patients and their families, are Dr. Benjamin Greene, Dr. Brian Hughley and Dr. Erin Buczek. They are head and neck surgeons at UAB Medicine.

Percutaneous ablation is a minimally invasive procedure where small needles are inserted through the skin under imaging guidance. The needles are directed toward tumors, which can be in the liver, kidney, bone, or lung. Once the needles are in place, the tumors are destroyed by either heating or freezing the cancer cells.

These treatments are faster and safer than traditional surgery. For many types of cancers, our results with ablation are equivalent to traditional surgical approaches. Apart from these benefits, many of our patients can go home the same day or the next day with only a band aid. Thus, our recovery time is much faster than traditional surgical approaches.

In this segment, Dr. Andrew Gunn discusses ablation for kidney & liver tumors and when to refer to a specialist.

The mission of the UAB Medicine Comprehensive Ovarian Cancer Program is to improve the lives of women affected by or at risk for ovarian cancer. This navigator-driven, patient-centric program is the first of its kind in the Southeast and centralizes important ancillary aspects of ovarian cancer care for patients and their families, including genetic counseling, supportive care, and nutritional counseling.

In this segment, Dr. Warner Huh discusses the Comprehensive Ovarian Cancer Program at UAB Medicine and when a referral to this program might be indicated.

UAB, has strived to incorporate robotic surgery into as many disciplines as possible, as this technology allows surgeons to perform many types of complex procedures with unprecedented control and precision. Robotic-assisted surgery usually leads to shorter hospital stays, faster recovery and minimized complications and functions as a safe platform for teaching surgical residents.

UAB has three of the da Vinci Si surgical systems, a next-generation robot that retains and builds on the core technology at the heart of the existing da Vinci and da Vinci S systems. UAB also has one of the newest Xi systems and will receive delivery of another this month. Da Vinci Xi is the next frontier for minimally invasive surgery.

During the last 40 years, researchers have demonstrated that prophylactic mastectomy — whether contralateral or bilateral — can reduce the risk for breast cancer occurrence in women at high risk by nearly 95%.

Listen as Helen Krontiras, MD discusses UAB’s Lynne Cohen Preventive Care Program for Women's Cancer, which provides comprehensive risk assessment and prevention for breast, ovarian, and uterine cancer, arming patients with knowledge to make informed decisions about their cancer risk and care.

For some time now, there has been significant interest in understanding and defining the role of minimally invasive surgery in colorectal cancer. Laparoscopic surgery has been shown to have similar or better outcomes compared with open surgery.

Patients who choose UAB Medicine for their gastrointestinal cancer care will benefit from a pacesetting team of specialists, state-of-the-art technology, and many treatments not available at other centers. Our outstanding physicians and surgeons work with members of the departments of Radiation Oncology and Radiology and the divisions of Hematology/Oncology, Gastroenterology, and Endoscopy to provide you with the latest diagnostic and therapeutic options.

Listen in as Gregory Kennedy, MD explains the advantages of using minimally invasive surgery in the treatment of colon and rectal disease.

Cancer patients face many challenges as they battle the disease. Treatment takes a toll on physical function and mental stress. Physical therapy improves mood through appropriate exercise. It also aids in gradual improvement of strength and function in the areas affected by cancer treatment.

In this powerful panel discussion Karen Ciardullo RN, BSN and Kiamesha Dolson-Ostrander, LMSW share information on the Littman Cancer Center's patient navigation program and the importance of helping patients deal with every aspect of their cancer journey.

Radiation oncology is important in the treatment of cancer, and Cornwall Radiation Oncology Services (CROS) is committed to providing the highest-quality care to residents of the Hudson Valley and beyond.

Shana Coplowitz, MD, dispels some common misconceptions people have about radiation therapy, the safety precautions taken and why it might be the right treatment option for you.

As the number of pediatric cancer survivors continues to grow as treatments become more effective, considerations regarding the long-term effects of therapy have become more important—though the effects may be unpredictable. Dr. Holly Hoefgen joins the show to discuss how fertility preservation offers young cancer survivors options to have children in the future.

Childhood cancer survival is one of the greatest success stories of medicine in recent years. Since the 1970's, the cure rate and number of survivors has grown dramatically. As the number of survivors of childhood cancer continues to grow, so does knowledge of the late effects of cancer treatment.

More than two-thirds of young adult survivors of childhood cancer eventually experience at least one "late effect," with some survivors experiencing more. Late effects can occur in any organ or system of the body and vary from person to person.

In this segment, Bob Hayashi, MD., discusses late side effects of chemotherapy and when to refer to a specialist in this program at SLCH.

Thirty percent of the approximately 12,500 children diagnosed with cancer each year may have a genetic cause for their disease.

A promising area of research in childhood cancer is genomic medicine, in which the genes of children with certain cancer diagnoses are closely examined. Advances in this field have shown that certain childhood cancers are related to specific genetic variations. Some of these same genetic changes may also cause other physical or developmental differences, and when grouped together, are considered to be a cancer predisposition syndrome.

In this segment, Dr Todd Druley explains how The Pediatric Cancer Predisposition Program at Siteman Kids at St. Louis Children's Hospital and Washington University School of Medicine seeks to identify at-risk children through genetic testing and diagnostic screenings, and can increase the likelihood of early detection and treatment.

St. Louis Children's Hospital (SLCH) and Siteman Cancer Center have joined forces against pediatric cancer by establishing "Siteman Kids at St. Louis Children's Hospital.

The partnership is focused on caring for children and adolescents with cancer, using the latest, most effective treatments, in a setting that's specifically geared to younger patients and their families.

In this segment, Dr. Bob Hayashi discusses Siteman Kids at St. Louis Children's Hospital and the exciting new advancements in pediatric oncology available at SLCH.

According to the NIH, the number of pediatric cancer survivors is growing rapidly as treatments become more effective. However, many current regimens can cause gonadotoxicity and permanent infertility, significantly impacting quality of life of these patients. Numerous treatment options are already available to prevent infertility in patients at risk.

In this segment, Dr. Kenan Omurtag, and Dr. Emily Jungheim, both Washington University reproductive endocrinologists and infertility specialists, discuss fertility preservation for pediatric cancer patients, at what point preservation modalities should be considered, when a fertility specialist should be brought in, as well as new scientific advances in this area.

In the US alone, more than 2 million Americans will be diagnosed in 2010 with nonmelanoma skin cancer, and 68,130 will be diagnosed with melanoma, according to the American Cancer Society.

Fortunately, skin cancers (basal cell and squamous cell carcinoma, and malignant melanoma) are rare in children. When melanomas occur, they usually arise from pigmented nevi (moles) that are large (diameter greater than 6 mm), asymmetric, with irregular borders and coloration. Bleeding, itching, and a lump under the skin are other signs of cancerous change. If a child has had radiation treatment for cancer, moles in the radiated area are at increased risk of becoming cancerous.

In this segment, Carrie Coughlin, MD, Washington University pediatric dermatologist at St. Louis Children's Hospital, discusses nevi (moles) and melanoma in children and when to refer to a specialist.

As part of our focus on breast cancer for Breast Cancer Awareness Month, surgical oncologist, Dr. Maureen Chung, who specializes in breast cancer surgery, goes over breast cancer screening guidelines, recommendations on prevention, detection and treatment for different ages of women, and lifestyle factors that do or do not actually contribute to breast cancer risk.

Author, mother, entrepreneur, and activist Tracy Nicole is also a breast cancer survivor. She joins Dr. Darria to share her story.

Author, mother, entrepreneur, and activist Tracy Nicole is also a breast cancer survivor.

Diagnosed on her first and last mammogram, Tracy talks about her decision to undergo a mastectomy, the struggles she went through telling her friends, mother and daughters about her diagnosis, and how she found an outlet through writing.

A diagnosis of cancer is life changing, and some cancer treatments such as chemotherapy, radiation and surgery can speed up the natural decline in available eggs, thereby reducing or destroying the egg reserve. It helps to know your options when considering fertility preservation.

Dr. Virginia Mensah shares fertility preservation options available at The Reproductive Science Center of New Jersey.

Patients at Riverside Cancer Institute in need of radiation therapy now have access to the most advanced treatment technology. The new Discovery RT radiotherapy system reduces treatment times while enabling each patient's care team to personalize oncology treatment plans with improved accuracy and radiation dosing safety.

Dr. Alex Herskovic discusses our advanced low-dose CT system and it’s use in the fight against cancer, as we strive to keep each patient's best interests at the forefront of progress.

While you can't control the genetic factors that influence cancer risk, you can control diet and lifestyle factors. Dr. Everard Hughes, medical oncologist and hematologist, discusses cancer risks that we can control.

The National Cancer Institute estimates there are almost 200,000 newly diagnosed cases of prostate cancer in the United States annually. Prostate cancer is the second leading cause of cancer death in men in the United States with approximately 28,000 men dying of it each year.

Palmdale Regional Medical Center is committed to providing the best care for prostate cancer and high quality healthcare in a compassionate and efficient manner.

Monish Aron, MD, is here to explain all the treatments for prostate cancer available at Palmdale Regional Medical Center.